About

Bob Holmen, J.D., has over 25 years of experience working in and advising technology, healthcare, and financial services companies. He has engaged at every phase of corporate development, from formation to financing to operations to exiting, and has served in diverse roles from electrical engineer (Hughes Aircraft) to an associate at major law firms (Latham & Watkins, Morrison & Foerster), to general counsel for a series of technology and financial services companies, to co-founder and managing director for a family of venture funds (Miramar Venture Partners). Currently, Mr. Holmen provides legal services to investors through his boutique law firm Investor Counsel, focused on the venture capital and private equity markets. His work encompasses fund formation, financing and operations, structuring, and negotiating investments, mergers and acquisition, and purchaser representation. In addition, he continues to serve as a Managing Director for the legacy (fully invested) Miramar Venture Partners funds. Mr. Holmen also has served as an adjunct professor, teaching “Venture Capital Law” at the UC Irvine Law School and “Investing in New Ventures” at USC’s Marshall School of Business, in addition to writing about venture and M&A matters. He received his B.S. in electrical engineering from Stanford University and his J.D. from UC Berkeley School of Law.

Kristian Humer, MBA, was appointed to Sensei’s board of directors in August 2021. Mr. Humer spent 20 years on Wall Street, including 14 years as a life science-focused investment banker. Most recently Kristian served as chief financial officer and chief business officer at Viridian Therapeutics (NASDAQ: VRDN) beginning in July 2021. Previously, he spent 11 years with Citigroup, Inc., most recently as managing director, where he helped lead the firm’s investment banking engagements for small and mid-sized biopharma and select large cap pharmaceutical companies. Prior to joining Citigroup, Inc., Mr. Humer served as vice president of the Investment Banking Division for the Global Healthcare Group team at Lehman Brothers, Inc. Mr. Humer started his career serving positions of increasing responsibility in the investment banking and private banking divisions of UBS AG and Merrill Lynch (a Bank of America company). He received an MBA from the Fuqua School of Business at Duke University and a B.A. with honors in accounting and economics from the University of Reading, United Kingdom.

Tom Ricks, MBA, has been a member of the Board of Directors since 2015. Mr. Ricks is the former chief investment officer of H&S Ventures LLC, a private investment firm. Prior to taking this position with H&S Ventures, he was chief executive officer of The University of Texas Investment Management Company. Mr. Ricks also served as vice chancellor for asset management for The University of Texas System and as executive director of finance and private investments. He has been a director of Newfield Exploration Company (NYSE:NFX) since 1992 and is chairman of its Audit Committee. He is a former director of BDM International, DTM Corporation, LifeCell Corporation, and Argus Pharmaceuticals. Mr. Ricks also previously served on the Investment Committee of the University of California Foundation, Irvine, and previously served on the board of the Ocean Institute. Mr. Ricks holds a B.A. in economics from Trinity College, and an MBA from the University of Chicago.